{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:11:40Z","timestamp":1785553900001,"version":"3.56.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jtha.2022.11.041","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T10:24:19Z","timestamp":1674642259000},"page":"838-849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["An HPA-1a\u2013positive platelet\u2013depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo\u2013controlled, single-center, phase 1\/2 proof-of-concept study"],"prefix":"10.1016","volume":"21","author":[{"given":"Christof","family":"Geisen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Kjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Fleck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjorn","family":"Skogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f3is\u00edn","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubin","family":"Bhagwagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Braeuninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Mortberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus Juel","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan Martin","family":"Gast\u00f3n Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhard","family":"Seifried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta","family":"Wikman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kjeldsen-Kragh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Koehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2022.11.041_bib1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ajog.2021.04.211","article-title":"New developments in fetal and neonatal alloimmune thrombocytopenia","volume":"225","author":"Bussel","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jtha.2022.11.041_bib2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1542\/peds.2013-3320","article-title":"Incidence and consequences of neonatal alloimmune thrombocytopenia: a systematic review","volume":"133","author":"Kamphuis","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jtha.2022.11.041_bib3","first-page":"194","article-title":"Neurodevelopmental outcome of term infants with intraventricular hemorrhage","volume":"146","author":"Jocelyn","year":"1992","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jtha.2022.11.041_bib4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00005-015-0371-9","article-title":"Fetal\/neonatal alloimmune thrombocytopenia: pathogenesis, diagnostics and prevention","volume":"64","author":"Brojer","year":"2016","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.jtha.2022.11.041_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1423-0410.2003.00302.x","article-title":"Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?","volume":"84","author":"Radder","year":"2003","journal-title":"Vox Sang"},{"key":"10.1016\/j.jtha.2022.11.041_bib6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1537-2995.2007.01208.x","article-title":"Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia","volume":"47","author":"Ghevaert","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.jtha.2022.11.041_bib7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(89)91733-9","article-title":"348 Cases of suspected neonatal alloimmune thrombocytopenia","volume":"1","author":"Mueller-Eckhardt","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2022.11.041_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.102704","article-title":"Epidemiology and management of fetal and neonatal alloimmune thrombocytopenia","volume":"59","author":"de Vos","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jtha.2022.11.041_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.semperi.2008.10.003","article-title":"Current approaches to the evaluation and management of the fetus and neonate with immune thrombocytopenia","volume":"33","author":"Bussel","year":"2009","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.jtha.2022.11.041_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.tmrv.2020.09.004","article-title":"Fetal and neonatal alloimmune thrombocytopenia-new prospects for fetal risk assessment of HPA-1a-negative pregnant women","volume":"34","author":"Kjeldsen-Kragh","year":"2020","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jtha.2022.11.041_bib11","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/ATVBAHA.116.307281","article-title":"Antiendothelial \u03b1v\u03b23 antibodies are a major cause of intracranial bleeding in fetal\/neonatal alloimmune thrombocytopenia","volume":"36","author":"Santoso","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2022.11.041_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.gendis.2015.02.003","article-title":"Platelets and platelet\u00a0alloantigens: lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopenia","volume":"2","author":"Vadasz","year":"2015","journal-title":"Genes Dis"},{"key":"10.1016\/j.jtha.2022.11.041_bib13","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1182\/bloodadvances.2020002137","article-title":"Fetal\/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3\u221701:01 on fetal\/neonatal outcome","volume":"4","author":"Kjeldsen-Kragh","year":"2020","journal-title":"Blood Advances"},{"key":"10.1016\/j.jtha.2022.11.041_bib14","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/trf.15152","article-title":"Risk of HPA-1a-immunization in HPA-1a-negative women after giving birth to an HPA-1a-positive child","volume":"59","author":"Kjeldsen-Kragh","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.jtha.2022.11.041_bib15","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3324\/haematol.12515","article-title":"A\u00a0prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn","volume":"93","author":"Killie","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2022.11.041_bib16","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood.V92.7.2280","article-title":"The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening","volume":"92","author":"Williamson","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.11.041_bib17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/bjh.15813","article-title":"Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach","volume":"185","author":"Lieberman","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2022.11.041_bib18","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.3324\/haematol.2010.025106","article-title":"Fetal alloimmune thrombocytopenia and maternal intravenous immunoglobulin infusion","volume":"95","author":"Giers","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2022.11.041_bib19","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1055\/s-0037-1607055","article-title":"IVIG-associated maternal pancytopenia during treatment for neonatal alloimmune thrombocytopenia","volume":"7","author":"Herrmann","year":"2017","journal-title":"AJP Rep"},{"key":"10.1016\/j.jtha.2022.11.041_bib20","first-page":"1783","article-title":"Effects of antepartum therapy for fetal alloimmune thrombocytopenia on maternal lifestyle","volume":"29","author":"Rossi","year":"2016","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jtha.2022.11.041_bib21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00404-020-05618-y","article-title":"Non-invasive risk-assessment and bleeding prophylaxis with IVIG in pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia: management to minimize adverse events","volume":"302","author":"Wienzek-Lischka","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jtha.2022.11.041_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/AOG.0b013e3182765c63","article-title":"Maternal hemolysis after intravenous immunoglobulin treatment in fetal and neonatal alloimmune thrombocytopenia","volume":"121","author":"Rink","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jtha.2022.11.041_bib23","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/j.1537-2995.2011.03480.x","article-title":"Toward a prophylaxis against fetal and\u00a0neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model","volume":"52","author":"Tiller","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.jtha.2022.11.041_bib24","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1182\/blood-2005-06-2562","article-title":"A\u00a0novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy","volume":"107","author":"Ni","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.11.041_bib25","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1182\/bloodadvances.2018023341","article-title":"High-resolution mapping of the polyclonal immune response to the human platelet\u00a0alloantigen HPA-1a (Pl(A1))","volume":"2","author":"Zhi","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2022.11.041_bib26","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1182\/blood.2022015666","article-title":"Prophylactic administration of HPA-1a-specific antibodies prevents fetal\/neonatal alloimmune thrombocytopenia in mice","volume":"140","author":"Zhi","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.11.041_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.102712","article-title":"Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia","volume":"59","author":"Kj\u00e6r","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jtha.2022.11.041_bib28","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.4049\/jimmunol.1401599","article-title":"Characterization of a human platelet antigen-1a-specific monoclonal antibody derived from a B cell from a woman alloimmunized in pregnancy","volume":"194","author":"Eksteen","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jtha.2022.11.041_bib29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4049\/immunohorizons.2100097","article-title":"Prevention of fetal\/neonatal alloimmune thrombocytopenia in mice: biochemical and cell biological characterization of isoforms of a human monoclonal antibody","volume":"6","author":"M\u00f8rtberg","year":"2022","journal-title":"Immunohorizons"},{"key":"10.1016\/j.jtha.2022.11.041_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235807","article-title":"Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: a preventable disease that still produces significant morbidity and mortality in children","volume":"15","author":"Pegoraro","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2022.11.041_bib31","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.1537-2995.1990.30490273444.x","article-title":"Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects","volume":"30","author":"Sebring","year":"1990","journal-title":"Transfusion"},{"key":"10.1016\/j.jtha.2022.11.041_bib32","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1537-2995.2011.03442.x","article-title":"Recovery, survival, and function of transfused platelets and detection of platelet engraftment after allogeneic stem cell transplantation","volume":"52","author":"Vetlesen","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.jtha.2022.11.041_bib33","first-page":"71","article-title":"Establishment and validation of a laboratory assay for monitoring survival of transfused platelets: tracking HLA mismatch between donor and recipient","volume":"113(S1)","author":"Kjaer","year":"2018","journal-title":"Vox Sanguinis"},{"key":"10.1016\/j.jtha.2022.11.041_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jim.2016.04.001","article-title":"Sensitive detection of platelet-specific antibodies with a modified MAIPA using biotinylated antibodies and streptavidin-coated beads","volume":"434","author":"M\u00f6rtberg","year":"2016","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jtha.2022.11.041_bib35","first-page":"1","article-title":"Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura","volume":"38","author":"Harrington","year":"1951","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.jtha.2022.11.041_bib36","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1749-6632.1965.tb18984.x","article-title":"Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies","volume":"124","author":"Shulman","year":"1965","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jtha.2022.11.041_bib37","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1182\/blood-2003-11-3929","article-title":"A\u00a0single recombinant anti-RhD IgG prevents RhD immunization: association of RhD-positive red blood cell clearance rate with polymorphisms in the FcgammaRIIA and FcgammaIIIA genes","volume":"103","author":"Miescher","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.11.041_bib38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1055\/s-2008-1037080","article-title":"[Immuno-elimination and clearance of Rh-positive erythrocytes in Rh-negative volunteers following administration of anti-D-immunoglobulin]","volume":"43","author":"Maas","year":"1983","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.jtha.2022.11.041_bib39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2141.1965.tb06609.x","article-title":"Rate of removal from the circulation of red cells sensitized with different amounts of antibody","volume":"11","author":"Mollison","year":"1965","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2022.11.041_bib40","first-page":"63","article-title":"Clearance of Rh-positive red cells by low concentrations of Rh antibody","volume":"12","author":"Mollison","year":"1967","journal-title":"Immunology"},{"key":"10.1016\/j.jtha.2022.11.041_bib41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1246-7820(98)80409-6","article-title":"Anti-D immunoglobulin in Rh(D) negative volunteers: clearance of Rh(D) positive red cells and kinetics of serum anti-D levels","volume":"5","author":"Stucki","year":"1998","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.jtha.2022.11.041_bib42","first-page":"CD000020","article-title":"Anti-D administration in pregnancy for preventing Rhesus alloimmunisation","volume":"2013","author":"Crowther","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2022.11.041_bib43","first-page":"Cd000021","article-title":"Anti-D administration after childbirth for preventing Rhesus alloimmunisation","volume":"1997","author":"Crowther","year":"1997","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2022.11.041_bib44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0167-5699(98)01393-0","article-title":"An innate view of human pregnancy","volume":"20","author":"Sacks","year":"1999","journal-title":"Immunol Today"},{"key":"10.1016\/j.jtha.2022.11.041_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.102707","article-title":"Foetal and neonatal alloimmune thrombocytopenia: the role of the HLA-DRB3\u221701:01 allele for HPA-1a-immunisation and foetal\/neonatal outcome","volume":"59","author":"Kjeldsen-Kragh","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jtha.2022.11.041_bib46","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2141.1993.tb03151.x","article-title":"Concurrent label method with 111In and 51Cr allows accurate evaluation of platelet viability of stored platelet concentrates","volume":"84","author":"Holme","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2022.11.041_bib47","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood.V66.5.1105.1105","article-title":"Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement","volume":"66","author":"Hanson","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.11.041_bib48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.transci.2009.10.007","article-title":"In\u00a0vivo tracking of transfused platelets for recovery and survival studies: an appraisal of labeling methods","volume":"42","author":"van der Meer","year":"2010","journal-title":"Transfus Apher Sci"},{"issue":"s3","key":"10.1016\/j.jtha.2022.11.041_bib49","doi-asserted-by":"crossref","first-page":"53S","DOI":"10.1111\/j.1537-2995.2006.01018.x","article-title":"A\u00a0historical perspective on platelet radiolabeling techniques","volume":"46","author":"Taylor","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.jtha.2022.11.041_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.102711","article-title":"Fetal and neonatal alloimmune thrombocytopenia: the Norwegian management model","volume":"59","author":"Tiller","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jtha.2022.11.041_bib51","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1381\/096089206777346673","article-title":"Estimating blood volume in obese and morbidly obese patients","volume":"16","author":"Lemmens","year":"2006","journal-title":"Obes Surg"},{"key":"10.1016\/j.jtha.2022.11.041_bib52","article-title":"Anti-D administration in pregnancy for preventing Rhesus alloimmunisation","volume":"2015","author":"McBain","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2022.11.041_bib53","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.thromres.2004.06.038","article-title":"Growth and function of the normal human placenta","volume":"114","author":"Gude","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2022.11.041_bib54","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1537-2995.2008.01832.x","article-title":"Ultrastructural localization of glycoprotein IIIa (GPIIIa, beta 3 integrin) on placental syncytiotrophoblast microvilli: implications for platelet\u00a0alloimmunization during pregnancy","volume":"48","author":"Kumpel","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.jtha.2022.11.041_bib55","first-page":"65","article-title":"Effects of placental microparticles and platelets on in vitro cytokine profiles and their ability to cause an anti-HPA-1a antibody response in vivo","volume":"5(2)","author":"Eastlake","year":"2012","journal-title":"J Transfus Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622078229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622078229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:38:12Z","timestamp":1761536292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622078229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1538783622078229"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2022.11.041","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An HPA-1a\u2013positive platelet\u2013depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo\u2013controlled, single-center, phase 1\/2 proof-of-concept study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2022.11.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}